Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Lairez

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Aging Cell|May 17, 2024
Identification of Prominin-2 as a new player of cardiomyocyte senescence in the aging heartD Maggiorani, Y Santin, K Formoso, et al.
Biomed Research International|November 1, 2013
First evidence of increased plasma serotonin levels in Tako-Tsubo cardiomyopathyC Rouzaud Laborde, C Delmas, J Mialet-Perez, et al.
ESC Heart Failure|July 23, 2024
The D-HCM score, a new diagnostic tool for distinguishing hypertrophic cardiomyopathy from hypertensive cardiopathyG Domain, M Biscond, N Dognin, et al.
Diabetes & Metabolism|January 3, 2012
Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndromeB Vergès, A Avignon, F Bonnet, et al.
Archives of Cardiovascular Diseases|July 19, 2012
Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndromeB Vergès, A Avignon, F Bonnet, et al.
Orphanet Journal of Rare Diseases|July 8, 2025
The impact of limited healthcare access among patients with light chain and transthyretin amyloidosis: real-world survey during COVID-19 lockdown period in FranceD Guijarro, A Jobbe-Duval, S Aguilhon, et al.
International Journal of Cardiology|February 23, 2016
Intramyocardial transplantation of mesenchymal stromal cells for chronic myocardial ischemia and impaired left ventricular function: Results of the MESAMI 1 pilot trialD Guijarro, M Lebrin, O Lairez, et al.
Revue Neurologique|April 20, 2024
Transthyretin amyloid polyneuropathy in France: A cross-sectional study with 413 patients and real-world tafamidis meglumine use (2009-2019)D Adams, P Cintas, G Solé, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Aging Cell|May 17, 2024
Identification of Prominin-2 as a new player of cardiomyocyte senescence in the aging heartD Maggiorani, Y Santin, K Formoso, et al.
Biomed Research International|November 1, 2013
First evidence of increased plasma serotonin levels in Tako-Tsubo cardiomyopathyC Rouzaud Laborde, C Delmas, J Mialet-Perez, et al.
ESC Heart Failure|July 23, 2024
The D-HCM score, a new diagnostic tool for distinguishing hypertrophic cardiomyopathy from hypertensive cardiopathyG Domain, M Biscond, N Dognin, et al.
Diabetes & Metabolism|January 3, 2012
Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndromeB Vergès, A Avignon, F Bonnet, et al.
Archives of Cardiovascular Diseases|July 19, 2012
Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndromeB Vergès, A Avignon, F Bonnet, et al.
Orphanet Journal of Rare Diseases|July 8, 2025
The impact of limited healthcare access among patients with light chain and transthyretin amyloidosis: real-world survey during COVID-19 lockdown period in FranceD Guijarro, A Jobbe-Duval, S Aguilhon, et al.
International Journal of Cardiology|February 23, 2016
Intramyocardial transplantation of mesenchymal stromal cells for chronic myocardial ischemia and impaired left ventricular function: Results of the MESAMI 1 pilot trialD Guijarro, M Lebrin, O Lairez, et al.
Revue Neurologique|April 20, 2024
Transthyretin amyloid polyneuropathy in France: A cross-sectional study with 413 patients and real-world tafamidis meglumine use (2009-2019)D Adams, P Cintas, G Solé, et al.
Pageof 2